Stock Events

Stock Events

Kymera Therapeutics (KYMR) Q2 2025 Earnings

9MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.91

-0.8

-0.69

-0.58

Details

Expected EPS

-0.907013

Actual EPS

-0.82

Surprise EPS

0.09

Surprise Percent

+9.59%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.82 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.